Drug Dev Ind Pharm. 2008 Feb;34(2):117-33.

Advanced formulation design: improving drug therapies for the management of severe and chronic pain.

Miller DA, Dinunzio JC, Williams RO 3rd.

Source

College of Pharmacy, University of Texas at Austin, Austin, Texas 78712, USA.

Abstract

Chronic pain is a condition affecting a vast patient population and resulting in billions of dollars in associated health care costs annually. Sufferers from severe chronic pain often require [correction of requite] twenty-four hour drug treatment through intrusive means and/or repeated oral dosing. Although the oral route of administration is most preferred, conventional immediate release oral dosage forms lead to inconvenient and suboptimal drug therapies for the treatment of chronic pain. Effective drug therapies for the management of chronic pain therefore require advanced formulation design to optimize the delivery of potent analgesic agents. Ideally, these advanced delivery systems provide efficacious pain therapy with minimal side effects via a simple and convenient dosing regime. In this article, currently commercialized and developing drug products for pain management are reviewed with respect to dosage form design as well as clinical efficacy. The drug delivery systems reviewed herein represent advanced formulation designs that are substantially improving analgesic drug therapies.

PMID:: 18302030; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

Review

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Education

New England Research Institutes Inc.

Medical

Pain - MedlinePlus Health Information

Supplemental Content

Save items

Related citations in PubMed

Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). [Pain Pract. 2008]
Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, et al. Pain Pract. 2008 Jul-Aug; 8(4):287-313. Epub 2008 May 23.
Review Newer methods of delivery of opiates for relief of pain. [Drugs. 1985]
Review Newer methods of delivery of opiates for relief of pain.
Slattery PJ, Boas RA. Drugs. 1985 Dec; 30(6):539-51.
New delivery systems in pain management. [Nurs Clin North Am. 1987]
New delivery systems in pain management.
Paice JA. Nurs Clin North Am. 1987 Sep; 22(3):715-26.
Review Management of pain in the cancer patient. [Clin Ther. 1993]
Review Management of pain in the cancer patient.
Skaer TL. Clin Ther. 1993 Jul-Aug; 15(4):638-49; discussion 637.
Review Choosing the right analgesic. A guide to selection. [Drugs. 1993]
Review Choosing the right analgesic. A guide to selection.
Bushnell TG, Justins DM. Drugs. 1993 Sep; 46(3):394-408.

See reviews... See all...

Cited by 3 PubMed Central articles

Effect of filtration on morphine and particle content of injections prepared from slow-release oral morphine tablets. [Harm Reduct J. 2009]
Effect of filtration on morphine and particle content of injections prepared from slow-release oral morphine tablets.
McLean S, Bruno R, Brandon S, de Graaff B. Harm Reduct J. 2009 Dec 22; 6:37. Epub 2009 Dec 22.
Tramadol: seizures, serotonin syndrome, and coadministered antidepressants. [Psychiatry (Edgmont). 2009]
Tramadol: seizures, serotonin syndrome, and coadministered antidepressants.
Sansone RA, Sansone LA. Psychiatry (Edgmont). 2009 Apr; 6(4):17-21.
Review A comparison of long- and short-acting opioids for the treatment of chronic noncancer pain: tailoring therapy to meet patient needs. [Mayo Clin Proc. 2009]
Review A comparison of long- and short-acting opioids for the treatment of chronic noncancer pain: tailoring therapy to meet patient needs.
Argoff CE, Silvershein DI. Mayo Clin Proc. 2009 Jul; 84(7):602-12.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Advanced formulation design: improving drug therapies for the management of seve...
Advanced formulation design: improving drug therapies for the management of severe and chronic pain.
Drug Dev Ind Pharm. 2008 Feb ;34(2):117-33.

PubMed
Analysis of FANCB and FANCN/PALB2 fanconi anemia genes in BRCA1/2-negative Spani...
Analysis of FANCB and FANCN/PALB2 fanconi anemia genes in BRCA1/2-negative Spanish breast cancer families.
Breast Cancer Res Treat. 2009 Feb ;113(3):545-51. Epub 2008 Feb 27 .

PubMed
Effect of low-complexity regions on protein structure determination.
Effect of low-complexity regions on protein structure determination.
J Struct Funct Genomics. 2007 Dec ;8(4):217-26. Epub 2008 Feb 27 .

PubMed
Physical activity and fracture risk: a prospective study of 1898 incident fractu...
Physical activity and fracture risk: a prospective study of 1898 incident fractures among 34,696 British men and women.
J Bone Miner Metab. 2008 ;26(2):191-8. Epub 2008 Feb 27 .

PubMed
Modeling individual-specific human optic nerve head biomechanics. Part II: influ...
Modeling individual-specific human optic nerve head biomechanics. Part II: influence of material properties.
Biomech Model Mechanobiol. 2009 Apr ;8(2):99-109. Epub 2008 Feb 27 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: